Literature DB >> 16371322

Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells.

K Saud1, R Herrera-Molina, R Von Bernhardi.   

Abstract

Pro-inflammatory molecules induce glial activation and the release of potentially detrimental factors capable of generating oxidative damage, such as nitric oxide (NO) and superoxide anion (O2.-). Activated glial cells (astrocytes and microglia) are associated to the inflammatory process in neurodegenerative diseases. A strong inflammatory response could escape endogenous control becoming toxic to neurons and contributing to the course of the disease. We evaluated in a hippocampal cells-microglia co-culture model, if the pro-inflammatory condition induced by lipopolysaccharide + interferon-gamma (LPS+IFN-gamma) promoted damage directly or if damage was secondary to glial activation. In addition, we explored the effect of the anti-inflammatory cytokine transforming growth factor-beta1 (TGF-beta1), and pro-inflammatory cytokines, interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on the regulation of the inflammatory response of microglia. We found that LPS+IFN-gamma-induced damage on hippocampal cultures was dependent on the presence of microglial cells. In hippocampal cultures exposed to LPS+IFN-gamma, TGF-beta1 was induced whereas in microglial cell cultures LPS+IFN-gamma induced the secretion of IL-1beta. TGF-beta1 and IL-1beta but not TNF-alpha decreased the NO production by 70-90%. PD98059, an inhibitor of MAP kinase (MEK), reduced the IFN-gamma-induced NO production by 40%. TGF-beta and IL-1beta reduced the IFN-gamma induced phosphorylation of ERK1,2 by 60% and 40%, respectively. However, the effect of IL-1beta was observed at 30 min and that of TGF-beta1 only after 24 h of exposure. We propose that acting with different timing, TGF-beta1 and IL-1beta can modulate the extracellular signal-regulated kinase ERK1,2, as a common element for different transduction pathways, regulating the amplitude and duration of glial activation in response to LPS+IFN-gamma. Cross-talk among brain cells may be key for the understanding of inflammatory mechanisms involved in pathogenesis of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371322     DOI: 10.1007/BF03033981

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  51 in total

Review 1.  Inflammation and therapeutic vaccination in CNS diseases.

Authors:  Howard L Weiner; Dennis J Selkoe
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

2.  The expression of transforming growth factor-beta1 (TGF-beta1) in hippocampal neurons: a temporary upregulated protein level after transient forebrain ischemia in the rat.

Authors:  Y Zhu; S Roth-Eichhorn; N Braun; C Culmsee; A Rami; J Krieglstein
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

Review 3.  TGF-beta latency: biological significance and mechanisms of activation.

Authors:  P E Gleizes; J S Munger; I Nunes; J G Harpel; R Mazzieri; I Noguera; D B Rifkin
Journal:  Stem Cells       Date:  1997       Impact factor: 6.277

Review 4.  Microglial secretion products and their impact on the nervous system.

Authors:  D Giulian; M Corpuz
Journal:  Adv Neurol       Date:  1993

5.  GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures.

Authors:  S C Lee; W Liu; C F Brosnan; D W Dickson
Journal:  Glia       Date:  1994-12       Impact factor: 7.452

6.  Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta.

Authors:  V A Vincent; F J Tilders; A M Van Dam
Journal:  Glia       Date:  1997-03       Impact factor: 7.452

Review 7.  Latent transforming growth factor-beta: structural features and mechanisms of activation.

Authors:  J S Munger; J G Harpel; P E Gleizes; R Mazzieri; I Nunes; D B Rifkin
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

8.  Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis.

Authors:  M Ding; B A St Pierre; J F Parkinson; P Medberry; J L Wong; N E Rogers; L J Ignarro; J E Merrill
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

9.  Cytokine modulation of murine microglial cell superoxide production.

Authors:  S Hu; W S Sheng; P K Peterson; C C Chao
Journal:  Glia       Date:  1995-01       Impact factor: 7.452

10.  The impact of microglia-derived cytokines upon gliosis in the CNS.

Authors:  D Giulian; J Li; X Li; J George; P A Rutecki
Journal:  Dev Neurosci       Date:  1994       Impact factor: 2.984

View more
  21 in total

1.  Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK.

Authors:  Xunrong Luo; Qiang Zhang; Victoria Liu; Zhenbiao Xia; Kathryn L Pothoven; Chung Lee
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

2.  Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation.

Authors:  Juan E Tichauer; Betsi Flores; Bernardita Soler; Laura Eugenín-von Bernhardi; Gigliola Ramírez; Rommy von Bernhardi
Journal:  Brain Behav Immun       Date:  2013-12-29       Impact factor: 7.217

3.  Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways.

Authors:  Rodrigo Herrera-Molina; Betsi Flores; Juan A Orellana; Rommy von Bernhardi
Journal:  J Neurochem       Date:  2012-08-22       Impact factor: 5.372

4.  Scavenger receptor class A ligands induce secretion of IL1β and exert a modulatory effect on the inflammatory activation of astrocytes in culture.

Authors:  B Godoy; P Murgas; J Tichauer; R Von Bernhardi
Journal:  J Neuroimmunol       Date:  2012-06-26       Impact factor: 3.478

5.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

Review 6.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

Review 7.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 8.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

9.  Potentiation and tolerance of toll-like receptor priming in human endothelial cells.

Authors:  Stephen R Koch; Fred S Lamb; Judith Hellman; Edward R Sherwood; Ryan J Stark
Journal:  Transl Res       Date:  2016-08-08       Impact factor: 7.012

10.  Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury.

Authors:  Galina Dvoriantchikova; David Barakat; Roberta Brambilla; Christian Agudelo; Eleut Hernandez; John R Bethea; Valery I Shestopalov; Dmitry Ivanov
Journal:  Eur J Neurosci       Date:  2009-07-09       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.